FLT3 and chronic myelogenous leukemia, BCR-ABL1 positive: Similarly, neither FLT3/ITD nor FLT3/D835 mutations were evident in any case of CML transforming to ALL or in T-All (0/11) which is consistent with the study by Anderson et al. 2008 (0% in 15 T-ALL patients).13 Some larger studies have reported a low frequency of FLT3/ITD and/or FLT3/D835 mutations ranging from 3.3% to 5.5% among T-ALL patients.18,39,46